There are a handful of successful reports on disease gene identification for cancer syndromes such as TERT promoter mutation47 and POT1 mutations48 in familial melanoma, POLE, POLD149 and FAN150 mutations in familial colorectal cancer and KDR mutation51 in familial Hodgkin lymphoma. This evidence concerns the gene POT1 and colorectal cancer.